Zoltán Kaló - Professor of Health Economics - Center for Health Technology Assessment, Semmelweis University | LinkedIn
ELTE Reader
Kutatóközpontok
Systematic review on the evaluation criteria of orphan medicines in Central and Eastern European countries
Zoltán Kaló - Professor of Health Economics - Center for Health Technology Assessment, Semmelweis University | LinkedIn
Rektori kiválósági különdíj - galéria
II. ELTE Biotechnológia FIEK szimpózium
Könyv: Bevezetés a szerhasználó nők világába (Kaló Zsuzsa)
ELTE Reader
Balázs Nagy – Jonathan D. Campbell – Zoltán Kaló (eds): The role of modelling in economic evaluations in health care | ELTE Reader
Sağlık Bilimleri Üniversitesi - Sağlık Ekonomisi Eğitimi Programı 2
A HAZAI GYÓGYSZERPOLITIKA KOCKÁZATAI: KÉRDEZZE MEG KEZELŐORVOSÁT, GYÓGYSZERÉSZÉT! Kaló Zoltán Egészség-gazdaságt
Sikereink
Prof. Zoltán Kaló PhD András Borsi PhD(c)
Framework for HTA Implementation - ppt download
▻ Limited human resources and budget for HTA implementation ▻ At Western European prices medicines are usually not cost-effe
PDF) Implication of external price referencing and parallel trade on pharmaceutical expenditure: Indirect evidence from lower-income European countries
Gaining an Appreciation of the Complexity of the Pharmaceutical R&D Process | Department of Public Policy
EPHA on Twitter: ""#Valletta has not reached any real progress yet. We are exchanging knowledge, taking steps towards #transparency, but real progress is not yet there." Paola Testori Coggi @Aifa_ufficiale #Trailblazers2025" /